Skip to content

Oocyte Retrieval and Virtual Reality (REVPO)

Study of Analgesic Effect of Virtual Reality During Oocyte Retrieval in in Vitro Fecondation Protocols: Controlled Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04935658
Acronym
REVPO
Enrollment
150
Registered
2021-06-23
Start date
2021-06-09
Completion date
2024-07-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertilization in Vitro, Oocyte Retrieval, Pain

Keywords

Reproductive Techniques, Assisted, Oocyte retrieval, Virtual reality, Medically Assisted Procreation, Pain, Analgesia

Brief summary

The aim of the study is to ass wether or not the use of virtual reality during oocyte retrieval provides a better pain relief for patients, compared to a standard analgesic procedure.

Detailed description

Patients will be included during the consultation with the gynaecologist, whom will explain the protocol to the patient and give her the consent to sign. The patient will be then randomized by a computer (using the software REDCAP) into either the experimental group or the standard group. In the experimental group, a virtual reality device will be installed on the patient as soon as she arrives in the operating room, and the intervention will start after 3-5 minutes. In both group, the patient will benefit of a local anesthesia in the vagina, and if they want it of an oral analgesic before the intervention. Just at the end of the intervention, the pain will be evaluated orally by the nurse, using a Numeric Rating Scale. This consist of the Primary Outcome. After the intervention, the gynaecologist will fill a form assessing his satisfaction concerning the use of virtual reality during the intervention (efficacy, security...) One hour after the intervention, the patient will fill a form about her self-estimation of the post-procedural pain and her satisfaction concerning the use of virtual reality. The number of oocytes collected and the number of oocytes expected on the ultrasound monitoring will be gathered and a ratio will be calculated, in order to estimate the efficacy of the retrieval. Five days after the intervention, the patient will have to fill a form evaluating her consumption of painkillers during the 48hours following the intervention.

Interventions

DEVICEHypnotic relaxation induced by virtual reality (device)

A virtual reality device will be install on the patient 3-5 minutes before the beginning of the oocyte retrieval. The device will be wearing by the patient during the entire intervention and 2 minutes after the end of the ponction.

DRUGlocal anesthesia

standard anesthesic procedure

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

participants receive an intervention throughout the protocol

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 43 years * First attempt of oocyte retrieval under local anesthesia in the context of a protocol for Medically Assisted Procreation

Exclusion criteria

* Former attempt of oocyte retrieval * Poor oocyte stock : \> 40 years AND low markers (AMH \< 0.5-1.1 ng/ml OR AFC \< 5-7) * Unsteady epilepsia

Design outcomes

Primary

MeasureTime frameDescription
Pain during oocyte retrieval, assessed by NRSday 0 (During the intervention for oocyte retrieval)Oral evaluation of pain during the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).

Secondary

MeasureTime frameDescription
Pain after oocyte retrieval, assessed by NRShour 1 (In the hour following the oocyte retrival)Written evaluation of pain after the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
Painkillers consumption during the 48 hours following the oocyte retrieval.Day 5Written auto-evaluation (questionnaire) of the amount and type of painkillers taken by the patient during the 48hours following the intervention
Patient satisfaction concerning the use of virtual reality during the oocyte retrievalhour 1 (In the hour following the oocyte retrival)Written evaluation of the patient global satisfaction concerning the virtual reality during the oocyte retrieval. (2 questions : Concerning the use of virtual reality during the oocyte retrieval, are you : very satisfied, little satisfied, not satisfied, not at all satisfied; if you had to re-take an oocyte retrieval, would you : do it again with virtual reality, do it again without virtual reality, do it under general anesthesia)
Gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrievalhour 1 (In the hour following the oocyte retrival)Written evaluation of the gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval (4 questions : Concerning the security during the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied, Concerning the easiness of the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied, During the oocyte retrieval, the patient seemed : very relaxed, relaxed, not relaxed, not at relaxed; as a whole, if this patient should re-take an oocyte retrieval, ould you recommend the use of virtual reality? Yes/No, can you tell us why in a few words)
Efficacy of the use of virtual reality during oocyte retrievalhour 1 (In the hour following the oocyte retrival)Ratio between the number of oocytes collected during the retrieval compared to the number of oocytes expected on the ultrasound monitoring

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026